.:. Consultation > Liste par auteurs > Balkau .:.

49 documents classés par : Date Titre Nom du premier auteur Type de documents Date de dépôt

1 - 2 - 3 - 4 - 5

Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. André P., Balkau B., Born C., Charles M.-A., Eschwège E., Study Group T. D. Diabetologia 49 (2006) 2599-603 [inserm-00126584 - version 1]

Bardet-Biedl syndrome gene variants are associated with both childhood and adult common obesity in French Caucasians. Benzinou M., Walley A., Lobbens S., Charles M.-A., Jouret B., Fumeron F., Balkau B., Meyre D., Froguel P. Diabetes 55, 10 (2006) 2876-82 [hal-00174354 - version 1]

Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Cauchi S., Meyre D., Dina C., Choquet H., Samson C., Gallina S., Balkau B., Charpentier G., Pattou F., Stetsyuk V. et al Diabetes 55, 10 (2006) 2903-8 [hal-00173852 - version 1]

Assessment of diabetes screening by general practitioners in France: the EPIDIA Study. Cogneau J., Balkau B., Weill A., Liard F., Simon D. Diabet Med 23 (2006) 803-7 [inserm-00128528 - version 1]

Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis. Hillier T. A., Rousseau A., Lange C., Lépinay P., Cailleau M., Novak M., Calliez E., Ducimetière P., Balkau B. Diabetologia 49, 7 (2006) 1528-35 [inserm-00128639 - version 1]

The impact of 3-year changes in lifestyle habits on metabolic syndrome parameters: the D.E.S.I.R study. Balkau B., Vierron E., Vernay M., Born C., Arondel D., Petrella A., Ducimetière P. European Journal of Cardiovascular Prevention & Rehabilitation 13, 3 (2006) 334-40 [inserm-00126586 - version 1]

The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. Jaziri R., Lobbens S., Aubert R., Péan F., Lahmidi S., Vaxillaire M., Porchay I., Bellili N., Tichet J., Balkau B. et al Diabetes 55, 4 (2006) 1157-62 [hal-00174453 - version 1]

The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. Jaziri R., Lobbens S., Aubert R., Péan F., Lahmidi S., Vaxillaire M., Porchay I., Bellili N., Tichet J., Balkau B. et al Diabetes 55, 4 (2006) 1157-62 [hal-00093822 - version 1]

Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study. Balkau B., Sapinho D., Petrella A., Mhamdi L., Cailleau M., Arondel D., Charles M.-A. Eur J Clin Nutr 60, 3 (2006) 295-304 [inserm-00128602 - version 1]

ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Bouatia-Naji N., Meyre D., Lobbens S., Séron K., Fumeron F., Balkau B., Heude B., Jouret B., Scherer P. E., Dina C. et al Diabetes 55, 2 (2006) 545-50 [hal-00174464 - version 1]